Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway

Diabetic nephropathy (DN) is the leading cause of end-stage failure of the kidney, but the efficacy of current strategies available for the prevention of DN remains unsatisfactory. The purpose of this study was to assess whether sitagliptin (SIT) has therapeutic potential for prevention of DN and to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Med
Main Authors: Wang, Dongdong, Zhang, Guanying, Chen, Xiao, Wei, Tong, Liu, Chenxu, Chen, Chun, Gong, Yinhan, Wei, Qunli
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2018
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5846674/
https://ncbi.nlm.nih.gov/pubmed/29484381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2018.3504
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados